RMEBX
Price
$57.84
Change
-$0.46 (-0.79%)
Updated
Jun 13 closing price
Net Assets
105.76B
SWDSX
Price
$16.91
Change
-$0.15 (-0.88%)
Updated
Jun 13 closing price
Net Assets
542.87M
Interact to see
Advertisement

RMEBX vs SWDSX

Header iconRMEBX vs SWDSX Comparison
Open Charts RMEBX vs SWDSXBanner chart's image
American Funds American Mutual R2E
Price$57.84
Change-$0.46 (-0.79%)
VolumeN/A
Net Assets105.76B
Schwab Dividend Equity
Price$16.91
Change-$0.15 (-0.88%)
VolumeN/A
Net Assets542.87M
RMEBX vs SWDSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMEBX vs. SWDSX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Buy and SWDSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. SWDSX (543M). SWDSX pays higher dividends than RMEBX: SWDSX (1.79) vs RMEBX (1.16). RMEBX was incepted earlier than SWDSX: RMEBX (11 years) vs SWDSX (22 years). RMEBX (1.07) is less costly to investors than SWDSX (0.89). RMEBX is a more actively managed with annual turnover of: 31.00 vs. SWDSX (12.00). SWDSX has a lower initial minimum investment than RMEBX: SWDSX (0) vs RMEBX (250). SWDSX annual gain was more profitable for investors over the last year : 15.65 vs. RMEBX (8.54). RMEBX return over 5 years is better than : 58.69 vs. SWDSX (49.28).
RMEBXSWDSXRMEBX / SWDSX
Total Expense Ratio1.070.89120%
Annual Report Gross Expense Ratio1.070.89120%
Fund Existence11 years22 years-
Gain YTD5.9235.056117%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets106B543M19,521%
Annual Yield % from dividends1.161.7965%
Returns for 1 year8.5415.6555%
Returns for 3 years27.8932.2187%
Returns for 5 years58.6949.28119%
Returns for 10 years68.227.43919%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EHC120.920.74
+0.62%
Encompass Health Corp
BHFAP19.66-0.01
-0.05%
Brighthouse Financial
AMRX7.75-0.21
-2.64%
Amneal Pharmaceuticals
ATAI2.11-0.07
-3.21%
ATAI Life Sciences NV
IMUX0.80-0.04
-4.62%
Immunic